Epigenetic Signatures of Cigarette Smoking
- PMID: 27651444
- PMCID: PMC5267325
- DOI: 10.1161/CIRCGENETICS.116.001506
Epigenetic Signatures of Cigarette Smoking
Abstract
Background: DNA methylation leaves a long-term signature of smoking exposure and is one potential mechanism by which tobacco exposure predisposes to adverse health outcomes, such as cancers, osteoporosis, lung, and cardiovascular disorders.
Methods and results: To comprehensively determine the association between cigarette smoking and DNA methylation, we conducted a meta-analysis of genome-wide DNA methylation assessed using the Illumina BeadChip 450K array on 15 907 blood-derived DNA samples from participants in 16 cohorts (including 2433 current, 6518 former, and 6956 never smokers). Comparing current versus never smokers, 2623 cytosine-phosphate-guanine sites (CpGs), annotated to 1405 genes, were statistically significantly differentially methylated at Bonferroni threshold of P<1×10-7 (18 760 CpGs at false discovery rate <0.05). Genes annotated to these CpGs were enriched for associations with several smoking-related traits in genome-wide studies including pulmonary function, cancers, inflammatory diseases, and heart disease. Comparing former versus never smokers, 185 of the CpGs that differed between current and never smokers were significant P<1×10-7 (2623 CpGs at false discovery rate <0.05), indicating a pattern of persistent altered methylation, with attenuation, after smoking cessation. Transcriptomic integration identified effects on gene expression at many differentially methylated CpGs.
Conclusions: Cigarette smoking has a broad impact on genome-wide methylation that, at many loci, persists many years after smoking cessation. Many of the differentially methylated genes were novel genes with respect to biological effects of smoking and might represent therapeutic targets for prevention or treatment of tobacco-related diseases. Methylation at these sites could also serve as sensitive and stable biomarkers of lifetime exposure to tobacco smoke.
Keywords: biomarkers; genome-wide association study; meta-analysis; methylation; smoking.
© 2016 American Heart Association, Inc.
Conflict of interest statement
B. M. P. serves on Data Safety Monitoring Board (DSMB) of a clinical trial of a device funded by the manufacturer (Zoll LifeCor) and on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. C.E.E. is currently employed by Astra Zeneca, although the work was completed prior to the employment. All other authors declare no conflicts of interest.
Figures
Similar articles
-
Novel DNA methylation signatures of tobacco smoking with trans-ethnic effects.Clin Epigenetics. 2021 Feb 16;13(1):36. doi: 10.1186/s13148-021-01018-4. Clin Epigenetics. 2021. PMID: 33593402 Free PMC article.
-
DNA methylation and smoking in Korean adults: epigenome-wide association study.Clin Epigenetics. 2016 Sep 22;8:103. doi: 10.1186/s13148-016-0266-6. eCollection 2016. Clin Epigenetics. 2016. PMID: 27688819 Free PMC article.
-
Longitudinal change in blood DNA epigenetic signature after smoking cessation.Epigenetics. 2022 Oct;17(10):1098-1109. doi: 10.1080/15592294.2021.1985301. Epub 2021 Oct 6. Epigenetics. 2022. PMID: 34570667 Free PMC article.
-
DNA methylation signature of passive smoke exposure is less pronounced than active smoking: The Understanding Society study.Environ Res. 2020 Nov;190:109971. doi: 10.1016/j.envres.2020.109971. Epub 2020 Jul 31. Environ Res. 2020. PMID: 32745538 Free PMC article. Review.
-
DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA1c levels: a systematic review and replication in a case-control sample of the Lifelines study.Diabetologia. 2018 Feb;61(2):354-368. doi: 10.1007/s00125-017-4497-7. Epub 2017 Nov 21. Diabetologia. 2018. PMID: 29164275 Free PMC article. Review.
Cited by
-
A Bivariate Twin Study of Lifetime cannabis Initiation and Lifetime Regular Tobacco Smoking Across Three Different Countries.Behav Genet. 2024 Jul 30. doi: 10.1007/s10519-024-10190-1. Online ahead of print. Behav Genet. 2024. PMID: 39078541
-
High-dimensional mediation analysis for continuous outcome with confounders using overlap weighting method in observational epigenetic study.BMC Med Res Methodol. 2024 Jun 3;24(1):125. doi: 10.1186/s12874-024-02254-x. BMC Med Res Methodol. 2024. PMID: 38831262 Free PMC article.
-
Smoking-informed methylation and expression QTLs in human brain and colocalization with smoking-associated genetic loci.Neuropsychopharmacology. 2024 Jun 4. doi: 10.1038/s41386-024-01885-4. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 38830989
-
Integrative analysis of genetics, epigenetics and RNA expression data reveal three susceptibility loci for smoking behavior in Chinese Han population.Mol Psychiatry. 2024 May 24. doi: 10.1038/s41380-024-02599-1. Online ahead of print. Mol Psychiatry. 2024. PMID: 38789676
-
Quantifying the stochastic component of epigenetic aging.Nat Aging. 2024 Jun;4(6):886-901. doi: 10.1038/s43587-024-00600-8. Epub 2024 May 9. Nat Aging. 2024. PMID: 38724732 Free PMC article.
References
-
- National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014. - PubMed
-
- World Health Organization. WHO global report on trends in prevalence of tobacco smoking. 2015
-
- Breitling LP, Salzmann K, Rothenbacher D, Burwinkel B, Brenner H. Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J. 2012;33:2841–2848. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 HL120163/HL/NHLBI NIH HHS/United States
- R01 HL104135/HL/NHLBI NIH HHS/United States
- Z01 ES043012-09/ImNIH/Intramural NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- R01 AR041398/AR/NIAMS NIH HHS/United States
- P30 ES023515/ES/NIEHS NIH HHS/United States
- 001/WHO_/World Health Organization/International
- MR/K026992/1/MRC_/Medical Research Council/United Kingdom
- ETM/55/CSO_/Chief Scientist Office/United Kingdom
- R01 HL101250/HL/NHLBI NIH HHS/United States
- G0700704/MRC_/Medical Research Council/United Kingdom
- R01 HL119443/HL/NHLBI NIH HHS/United States
- R01 HL105756/HL/NHLBI NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- U01 HL072524/HL/NHLBI NIH HHS/United States
- CZB/4/505/CSO_/Chief Scientist Office/United Kingdom
- R00 ES023450/ES/NIEHS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources